Home > Insider Trading > Filing (0001209191-23-044439)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1422142	Aadi Bioscience Inc.	AADI	Pharmaceutical Preparations (2834)	611547850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1878692	Neil Desai	C/O Aadi Bioscience, Inc. 17383 Sunset Boulevard, Suite A250 Pacific Palisades CA 90272	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-08-01	22,710	$5.22	1,724,833	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-08-02	19,290	$5.20	1,705,543	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	639,698	Indirect	See footnote

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.
Represents the weighted average share price of an aggregate total of 22,710 shares sold in the price range of $5.12 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.
Represents the weighted average share price of an aggregate total of 19,290 shares sold in the price range of $5.09 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares held by Anishka Irrevocable 2016 Trust dated October 19, 2016 (the "Irrevocable Trust"). The Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust except to the extent of any pecuniary interest therein, and this filing shall not be deemed an admission that Dr. Desai is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.